» Articles » PMID: 34053467

Exosomal LncRNA UCA1 Modulates Cervical Cancer Stem Cell Self-renewal and Differentiation Through MicroRNA-122-5p/SOX2 Axis

Overview
Journal J Transl Med
Publisher Biomed Central
Date 2021 May 31
PMID 34053467
Citations 27
Authors
Affiliations
Soon will be listed here.
Abstract

Background: There is growing evidence discussing the role of long non-coding RNAs (lncRNAs) in cervical cancer (CC). We performed this study to explore the impact of exosomal lncRNA urothelial cancer-associated 1 (UCA1) in CC stem cells by sponging microRNA-122-5p (miR-122-5p) and regulating SOX2 expression.

Methods: CC stem cells (CD133CaSki) and exosomes were extracted and identified. The synthesized UCA1- and miR-122-5p-related sequences were transfected into CaSki cells, CaSki cells-derived exosomes were extracted and then co-cultured with CD133CaSki cells. The functional roles of UCA1 and miR-122-5p in self-renewal and differentiation ability of CC stem cells were determined using ectopic expression, knockdown/depletion and reporter assay experiments. An in vivo experiment was performed to verify the in vitro results.

Results: Up-regulated UCA1 and SOX2 and down-regulated miR-122-5p were found in CaSki-Exo. Exosomes promoted invasion, migration, proliferation and restrained apoptosis of CD133CaSki cells. Silencing UCA1 or up-regulating miR-122-5p degraded SOX2 expression, and reduced invasion, migration and proliferation of CD133CaSki cells while advanced apoptosis and suppressed the tumor volume and weight in nude mice.

Conclusion: Our study provides evidence that CaSki-Exo can promote the self-renewal and differentiation ability of CC stem cells while silencing UCA1 or up-regulating miR-122-5p restrains self-renewal and differentiation of CC stem cells.

Citing Articles

The role of tumor-derived exosomal LncRNA in tumor metastasis.

Yu Z, Fu J, Mantareva V, Blazevic I, Wu Y, Wen D Cancer Gene Ther. 2025; .

PMID: 40011710 DOI: 10.1038/s41417-024-00852-x.


LncRNA-miRNA-mRNA regulatory axes as potential biomarkers in cervical cancer: a comprehensive overview.

Patel D, Thankachan S, Sreeram S, Kavitha K, Kabekkodu S, Suresh P Mol Biol Rep. 2025; 52(1):110.

PMID: 39775991 DOI: 10.1007/s11033-024-10215-2.


Advances and challenges in the use of liquid biopsy in gynaecological oncology.

Zhang Y, Tian L Heliyon. 2024; 10(20):e39148.

PMID: 39492906 PMC: 11530831. DOI: 10.1016/j.heliyon.2024.e39148.


Activation of the G Protein-Coupled Bile Acid Receptor TGR5 Modulates the HCP5/miR-139-5p/DDIT4 Axis to Antagonize Cervical Cancer Progression.

Su J, Zhao Y, Chen W, Wang Y Int J Mol Sci. 2024; 25(16).

PMID: 39201624 PMC: 11354701. DOI: 10.3390/ijms25168932.


Immunogenomic profiles and therapeutic options of the pan-programmed cell death-related lncRNA signature for patients with bladder cancer.

Yang J, Zhang L, Zhu B, Wu H, Peng M Sci Rep. 2024; 14(1):18500.

PMID: 39122807 PMC: 11316077. DOI: 10.1038/s41598-024-68859-w.


References
1.
Wang C, Zhu C, Xu J, Wang M, Zhao W, Liu Q . The lncRNA UCA1 promotes proliferation, migration, immune escape and inhibits apoptosis in gastric cancer by sponging anti-tumor miRNAs. Mol Cancer. 2019; 18(1):115. PMC: 6609402. DOI: 10.1186/s12943-019-1032-0. View

2.
Fan L, Huang C, Li J, Gao T, Lin Z, Yao T . Long non‑coding RNA urothelial cancer associated 1 regulates radioresistance via the hexokinase 2/glycolytic pathway in cervical cancer. Int J Mol Med. 2018; 42(4):2247-2259. DOI: 10.3892/ijmm.2018.3778. View

3.
Zhang W, Jiang H, Chen Y, Ren F . Resveratrol chemosensitizes adriamycin-resistant breast cancer cells by modulating miR-122-5p. J Cell Biochem. 2019; 120(9):16283-16292. DOI: 10.1002/jcb.28910. View

4.
Chen S, Zhu J, Wang F, Guan Z, Ge Y, Yang X . LncRNAs and their role in cancer stem cells. Oncotarget. 2018; 8(66):110685-110692. PMC: 5746414. DOI: 10.18632/oncotarget.22161. View

5.
Zhou Y, Meng X, Chen S, Li W, Li D, Singer R . IMP1 regulates UCA1-mediated cell invasion through facilitating UCA1 decay and decreasing the sponge effect of UCA1 for miR-122-5p. Breast Cancer Res. 2018; 20(1):32. PMC: 5907460. DOI: 10.1186/s13058-018-0959-1. View